CSC Biomarkers for Early Detection

Detecting cancer at an early stage is critical for improving patient outcomes, and cancer stem cells (CSCs) offer potential biomarkers for early diagnosis. This track focuses on identifying CSC-specific biomarkers, such as surface markers, secreted proteins, and genetic signatures, that can be used to detect cancer at its earliest stages. Researchers investigate how these biomarkers could be used for non-invasive screening, such as liquid biopsies, to monitor disease progression or predict therapeutic response. Early detection of CSCs could lead to more timely and targeted interventions, preventing the development of advanced, treatment-resistant tumors. This research aims to improve cancer prognosis through better diagnostic tools.

    Related Conference of CSC Biomarkers for Early Detection

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CSC Biomarkers for Early Detection Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in